Schmidt M, KUmmel S, Ruf-Doerdelmann A, Distelrath A, et al. Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin((R))) in
Patients With Early HER2-positive Breast Cancer: Real World Data from a German
Observational Study - (NIS HerSCin). Anticancer Res 2021;41:485-496.
PMID: 33419847